Biden administration aims to increase Medicaid drug transparency
The notice of proposed rulemaking recommends that the CMS and states get a drug price verification survey tool to verify prices and negotiate for expensive drugs under Medicaid.
The notice of proposed rulemaking recommends that the CMS and states get a drug price verification survey tool to verify prices and negotiate for expensive drugs under Medicaid.